http://www.bing.com:80/search?q=SurePath+LabSearch resultshttp://www.bing.com:80/s/a/rsslogo.gifhttp://www.bing.com:80/search?q=SurePath+LabCopyright © 2026 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.https://www.bd.com/en-us/products-and-solutions/products/product-brands/surepathOur BD SurePath™ brand defines a liquid-based Pap test that improves disease detection.Mon, 20 Apr 2026 22:42:00 GMThttps://www.surepath.ai/SurePath AI is a SaaS platform that governs any GenAI solutions you build, adopt, or buy—even Shadow AI.Thu, 23 Apr 2026 03:26:00 GMThttps://testdirectory.questdiagnostics.com/test/test-detail/14471/surepath-pap?cc=MASTERSurePath™ Pap - Liquid based Pap testing is intended for use in the screening and detection of cervical cancer, pre-cancerous lesions, atypical cells and all other cytologic categories as defined by the Bethesda System for Reporting Results of Cervical Cytology.Wed, 22 Apr 2026 02:59:00 GMThttps://www.healthcare.uiowa.edu/path_handbook/extras/BD-Surepath-New-Vial-collection-lit.pdfThe BD SurePath Collection Vial offers standardization and positive sample identification, while providing physicians with a single-source collection for Pap screening and molecular diagnostic testing.Tue, 21 Apr 2026 08:01:00 GMThttps://www.bd.com/en-us/products-and-solutions/products/product-families/bd-surepath-liquid-based-pap-testThe BD SurePath™ liquid-based Pap test provides advantages over conventional Pap smears and other liquid-based cytology (LBC) tests, resulting in greater disease detection.Mon, 20 Apr 2026 14:28:00 GMThttps://www.surepath.ai/company/aboutOur comprehensive platform governs end-user GenAI use, allowing businesses to harness public GenAI services, access private models, and control data flow—all while ensuring security and compliance.Wed, 22 Apr 2026 07:02:00 GMThttps://www.surepath.ai/solutionsTransform shadow AI into an advantage. Secure GenAI adoption with both public and private model management and visibility. Future-proof your enterprise AI strategy with SurePath.Mon, 20 Apr 2026 21:38:00 GMThttps://www.bd.com/en-us/products-and-solutions/products/product-page.491439The BD SurePath™ liquid-based Pap test provides advantages over conventional Pap smears and other liquid-based cytology (LBC) tests, resulting in greater disease detection.Wed, 22 Apr 2026 14:26:00 GMThttps://emea.bd.com/advancing-diagnostics/assays/cervical-cancer/bd-surepath/The BD SurePath™ collection vial is designed to improve patient care while providing physicians with the convenience of a single-source collection for Pap screening and molecular diagnostic testingTue, 21 Apr 2026 19:06:00 GMThttps://www.surepath.ai/blog/introducing-ai-assistantsWe’re excited to introduce SurePath AI Assistants, a powerful new way to streamline workflows and enhance productivity across your organization.Thu, 23 Apr 2026 01:24:00 GMT